U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may - Combination drug - Document - PDFSEARCH.IO

First Page	Meta Content
	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Open Document File Size: 76,76 KB Share Result on Facebook Company PR Newswire / / Country United States / / IndustryTerm combination product / insurance plans / inhaled combination product / credentialed media / media advisory / combination products / / MedicalCondition bronchospasms / breather disorders / COPD / really very sick asthma / patient’s asthma / severe asthma / disorders / asthma / / Organization National Institute of Health / Division of Pulmonary and Allergy Products / U.S. Food and Drug Administration / Center for Drug Evaluation and Research / FDA’s office of Public Affairs / / Person Janet Woodcock / Karen Riley / Joanne Silberner / Badrul Chowdhury / Robert Lovis / Cheryl Thompson / / Position pm EST Coordinator / Governor / Coordinator / Director / physician / controller / / Product Flovent / Symbicort / Serevent / Foradil / / PublishedMedium the American Journal / / URL www.fda.gov / / SocialTag Combination drugs Asthma GlaxoSmithKline Chronic lower respiratory diseases Fluticasone/salmeterol Salmeterol Formoterol Budesonide/formoterol Long-acting beta-adrenoceptor agonist Pulmonology

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List